Related Experiment Video
Updated: May 9, 2026

Mouse Models for Graft Arteriosclerosis
Published on: May 14, 2013
[Thromboprophylaxis in surgical patients]
Anne Godier1, Nadia Rosencher, Charles-Marc Samama
1Assistance publique-Hôpitaux de Paris, hôpital Cochin, université Paris-Descartes, service d'anesthésie-réanimation chirurgicale, France.
Thromboprophylaxis strategies differ based on surgery and patient factors, influencing both bleeding and clotting risks. Low molecular weight heparins are common, but new oral anticoagulants are increasingly preferred for major orthopedic procedures.
Area of Science:
- Pharmacology
- Vascular Surgery
- Anesthesiology
Context:
- Surgical procedures necessitate tailored thromboprophylaxis strategies to mitigate thromboembolic and bleeding risks.
- Patient-specific factors significantly influence the choice of anticoagulant and overall risk assessment.
- Current guidelines recommend varying approaches based on surgical type and individual patient profiles.
Purpose:
- To delineate the factors influencing thromboprophylaxis strategy selection in surgical patients.
- To compare the efficacy and safety profiles of different anticoagulant agents.
- To provide an overview of current practices in surgical thromboprophylaxis.
Summary:
- Thromboembolic and bleeding risks are intrinsically linked to surgical type and patient characteristics.
- Low molecular weight heparins are the predominant agents for surgical thromboprophylaxis.
- Novel oral anticoagulants are emerging as preferred alternatives in specific scenarios, notably major orthopedic surgery.
Impact:
- Informing clinical decision-making for optimal thromboprophylaxis in diverse surgical settings.
- Guiding the development of more personalized and effective anticoagulant protocols.
- Potentially reducing the incidence of surgical site complications and improving patient outcomes.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Peripheral Artery Disease V: Postoperative Nursing Management
Pulmonary Embolism III: Nursing Management